<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02789943</url>
  </required_header>
  <id_info>
    <org_study_id>2013/103/C</org_study_id>
    <nct_id>NCT02789943</nct_id>
  </id_info>
  <brief_title>Multi- Level and Integrated Analysis of Mechanisms Underlying Atrial Dysfunction</brief_title>
  <acronym>STaR-CABG</acronym>
  <official_title>The National Heart Centre Singapore Prospective CABG Cohort: Multi- Level and Integrated Analysis of Mechanisms Underlying Atrial Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Heart Centre Singapore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Duke-NUS Graduate Medical School</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Heart Centre Singapore</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Integrated and cross-disciplinary analysis of human physiology and disease provides unbiased
      and deeply informative insights into human health and disease. In this study the
      investigators will recruit patients undergoing coronary artery bypass surgery to study the
      atrium of the heart or the aortic wall that when diseased can cause strokes.

      Hypothesis: Systems-level analysis of the left atrium and aorta cells that integrates
      imaging, histological, cellular and molecular data will identify new mechanism for
      cardiovascular form and function.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      While there are many sub-aims to this study, the overarching goal is to define molecular
      mechanisms underlying atrial dysfunction. Here the investigator provide a power calculation
      based on detecting the genetic control points of gene expression (eQTLs) in the human atrial
      fibroblast. The investigator and many others have shown that tissue-specific eQTLs can be
      robustly identified at genome-wide significance in segregating populations of ~200. In this
      study the investigator propose eQTL association analysis in humans, which have previously
      been successfully performed in cohorts of less than 1000 subjects. The general applicability
      of this approach has been validated in multiple studies across multiple tissues in cohorts of
      between 200-1000 subjects.Based on published imaging genetic studies that have been
      successfully applied in small cohorts (&lt;500) and the success of echo-based, semi-quantitative
      studies of ventricular dimensions, the investigator are confident that our quantitative
      studies of 750 individuals are powered to detect genome wide significant loci for the traits
      under study.

      Despite intensive research there is a critical gap in our knowledge in the mechanisms
      underlying atrial fibrillation, which is a major cause of stroke and heart failure and
      increasingly common as it is a disease of the elderly. This project will address this
      important gap in our knowledge and provide new insights into disease pathogenesis with the
      goal of stratifying participants to prevent strokes and for treating the underlying
      substrate.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">April 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>First occurrence of cardiovascular event</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">750</enrollment>
  <condition>Ischemic Heart Disease</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cardiac Bypass Surgery</intervention_name>
    <description>elective cardiac bypass surgery during which a sample of right atrial appendage and/ or aortic button can be removed</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Tissue samples ( Atrial Appendage Tissue/ Aortic Button ) Blood Serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be recruited from wards or referral from clinics at the National Heart Centre
        Singapore if criteria is fulfil
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing elective cardiac bypass surgery during which a sample of right
             atrial appendage and/or aortic button can be removed.

        Exclusion Criteria:

          -  Infection within 2 weeks preceding the operation or immunosuppressive therapy.

          -  Patients not able or willing to consent for study.

          -  Previous atrial intervention.

          -  Patients who cannot be followed up.

          -  Exclude patients with significant valvular disease (any planned valvular surgery, MR &gt;
             severe, AS &gt; severe, TR &gt; severe).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stuart Alexander Cook</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Heart Centre Singapore / Duke NUS Graduate Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Muhammad Hafiz Jamal</last_name>
    <phone>97547816 /</phone>
    <phone_ext>+65</phone_ext>
    <email>muhd.hafiz.jamal@nhcs.com.sg</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Heart Centre</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Muhammad Hafiz Jamal</last_name>
      <phone>97547816</phone>
      <phone_ext>+65</phone_ext>
      <email>muhd.hafiz.jamal@nhcs.com.sg</email>
    </contact>
    <investigator>
      <last_name>Stuart Alexander Cook, MBBS,MRCP,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <reference>
    <citation>Hogue CW Jr, Creswell LL, Gutterman DD, Fleisher LA; American College of Chest Physicians. Epidemiology, mechanisms, and risks: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest. 2005 Aug;128(2 Suppl):9S-16S. Review.</citation>
    <PMID>16167659</PMID>
  </reference>
  <reference>
    <citation>Chew JT, Ong KK. Atrial arrhythmias post coronary bypass grafting. Singapore Med J. 1993 Oct;34(5):430-4.</citation>
    <PMID>8153692</PMID>
  </reference>
  <reference>
    <citation>Alexander KP, Peterson ED. Coronary artery bypass grafting in the elderly. Am Heart J. 1997 Nov;134(5 Pt 1):856-64. Review.</citation>
    <PMID>9398097</PMID>
  </reference>
  <reference>
    <citation>Ad N, Snir E, Vidne BA, Golomb E. Histologic atrial myolysis is associated with atrial fibrillation after cardiac operation. Ann Thorac Surg. 2001 Sep;72(3):688-93.</citation>
    <PMID>11565642</PMID>
  </reference>
  <reference>
    <citation>Ak K, Akgun S, Tecimer T, Isbir CS, Civelek A, Tekeli A, Arsan S, Cobanoglu A. Determination of histopathologic risk factors for postoperative atrial fibrillation in cardiac surgery. Ann Thorac Surg. 2005 Jun;79(6):1970-5.</citation>
    <PMID>15919294</PMID>
  </reference>
  <reference>
    <citation>Goette A, Juenemann G, Peters B, Klein HU, Roessner A, Huth C, Röcken C. Determinants and consequences of atrial fibrosis in patients undergoing open heart surgery. Cardiovasc Res. 2002 May;54(2):390-6.</citation>
    <PMID>12062343</PMID>
  </reference>
  <reference>
    <citation>Serri K, Reant P, Lafitte M, Berhouet M, Le Bouffos V, Roudaut R, Lafitte S. Global and regional myocardial function quantification by two-dimensional strain: application in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2006 Mar 21;47(6):1175-81. Epub 2006 Feb 23.</citation>
    <PMID>16545649</PMID>
  </reference>
  <reference>
    <citation>Richand V, Lafitte S, Reant P, Serri K, Lafitte M, Brette S, Kerouani A, Chalabi H, Dos Santos P, Douard H, Roudaut R. An ultrasound speckle tracking (two-dimensional strain) analysis of myocardial deformation in professional soccer players compared with healthy subjects and hypertrophic cardiomyopathy. Am J Cardiol. 2007 Jul 1;100(1):128-32. Epub 2007 May 21.</citation>
    <PMID>17599454</PMID>
  </reference>
  <reference>
    <citation>Weidemann F, Niemann M, Herrmann S, Kung M, Störk S, Waller C, Beer M, Breunig F, Wanner C, Voelker W, Ertl G, Bijnens B, Strotmann JM. A new echocardiographic approach for the detection of non-ischaemic fibrosis in hypertrophic myocardium. Eur Heart J. 2007 Dec;28(24):3020-6. Epub 2007 Nov 1.</citation>
    <PMID>17981828</PMID>
  </reference>
  <reference>
    <citation>Park TH, Nagueh SF, Khoury DS, Kopelen HA, Akrivakis S, Nasser K, Ren G, Frangogiannis NG. Impact of myocardial structure and function postinfarction on diastolic strain measurements: implications for assessment of myocardial viability. Am J Physiol Heart Circ Physiol. 2006 Feb;290(2):H724-31. Epub 2005 Sep 23.</citation>
    <PMID>16183729</PMID>
  </reference>
  <reference>
    <citation>Verma A, Wazni OM, Marrouche NF, Martin DO, Kilicaslan F, Minor S, Schweikert RA, Saliba W, Cummings J, Burkhardt JD, Bhargava M, Belden WA, Abdul-Karim A, Natale A. Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure. J Am Coll Cardiol. 2005 Jan 18;45(2):285-92.</citation>
    <PMID>15653029</PMID>
  </reference>
  <reference>
    <citation>Hwang HJ, Choi EY, Rhee SJ, Joung B, Lee BH, Lee SH, Kim J, Lee MH, Jang Y, Chung N, Kim SS. Left atrial strain as predictor of successful outcomes in catheter ablation for atrial fibrillation: a two-dimensional myocardial imaging study. J Interv Card Electrophysiol. 2009 Nov;26(2):127-32. doi: 10.1007/s10840-009-9410-y. Epub 2009 Jun 16.</citation>
    <PMID>19529886</PMID>
  </reference>
  <reference>
    <citation>Di Salvo G, Caso P, Lo Piccolo R, Fusco A, Martiniello AR, Russo MG, D'Onofrio A, Severino S, Calabró P, Pacileo G, Mininni N, Calabró R. Atrial myocardial deformation properties predict maintenance of sinus rhythm after external cardioversion of recent-onset lone atrial fibrillation: a color Doppler myocardial imaging and transthoracic and transesophageal echocardiographic study. Circulation. 2005 Jul 19;112(3):387-95. Epub 2005 Jul 8.</citation>
    <PMID>16006491</PMID>
  </reference>
  <reference>
    <citation>Kuppahally SS, Akoum N, Burgon NS, Badger TJ, Kholmovski EG, Vijayakumar S, Rao SN, Blauer J, Fish EN, Dibella EV, Macleod RS, McGann C, Litwin SE, Marrouche NF. Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: relationship to left atrial structural remodeling detected by delayed-enhancement MRI. Circ Cardiovasc Imaging. 2010 May;3(3):231-9. doi: 10.1161/CIRCIMAGING.109.865683. Epub 2010 Feb 4.</citation>
    <PMID>20133512</PMID>
  </reference>
  <reference>
    <citation>Anné W, Willems R, Roskams T, Sergeant P, Herijgers P, Holemans P, Ector H, Heidbüchel H. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation. Cardiovasc Res. 2005 Sep 1;67(4):655-66.</citation>
    <PMID>15913581</PMID>
  </reference>
  <reference>
    <citation>Ware JS, Petretto E, Cook SA. Integrative genomics in cardiovascular medicine. Cardiovasc Res. 2013 Mar 15;97(4):623-30. doi: 10.1093/cvr/cvs303. Epub 2012 Sep 27. Review.</citation>
    <PMID>23024270</PMID>
  </reference>
  <reference>
    <citation>Heinig M, Petretto E, Wallace C, Bottolo L, Rotival M, Lu H, Li Y, Sarwar R, Langley SR, Bauerfeind A, Hummel O, Lee YA, Paskas S, Rintisch C, Saar K, Cooper J, Buchan R, Gray EE, Cyster JG; Cardiogenics Consortium, Erdmann J, Hengstenberg C, Maouche S, Ouwehand WH, Rice CM, Samani NJ, Schunkert H, Goodall AH, Schulz H, Roider HG, Vingron M, Blankenberg S, Münzel T, Zeller T, Szymczak S, Ziegler A, Tiret L, Smyth DJ, Pravenec M, Aitman TJ, Cambien F, Clayton D, Todd JA, Hubner N, Cook SA. A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk. Nature. 2010 Sep 23;467(7314):460-4. doi: 10.1038/nature09386. Epub 2010 Sep 8.</citation>
    <PMID>20827270</PMID>
  </reference>
  <reference>
    <citation>Petretto E, Sarwar R, Grieve I, Lu H, Kumaran MK, Muckett PJ, Mangion J, Schroen B, Benson M, Punjabi PP, Prasad SK, Pennell DJ, Kiesewetter C, Tasheva ES, Corpuz LM, Webb MD, Conrad GW, Kurtz TW, Kren V, Fischer J, Hubner N, Pinto YM, Pravenec M, Aitman TJ, Cook SA. Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass. Nat Genet. 2008 May;40(5):546-52. doi: 10.1038/ng.134.</citation>
    <PMID>18443592</PMID>
  </reference>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 30, 2016</study_first_submitted>
  <study_first_submitted_qc>June 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2016</study_first_posted>
  <last_update_submitted>April 5, 2017</last_update_submitted>
  <last_update_submitted_qc>April 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>IHD Normal EF</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

